CoreAge Rx vs Telos Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Telos Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 85 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
That doesn't make Telos Rx a bad call — it's best for readers who want glp-1 care and a needle-free oral or microdosed route on the same certified provider that also carries peptides, nad+ and hrt — and will trade fda-approved brand access and up-front pricing for the deepest menu at the lowest annual-lock rate. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | Telos Rx | |
|---|---|---|
| Brief Score | 94/100 (A) | 85/100 (B) |
| Semaglutide | $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published | From $99/mo injectable — a floor, not a rate: Telos publishes "as low as $99" and says the price depends on plan length, which is shown only inside the intake |
| Tirzepatide | $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published | From $139/mo injectable · from $116/mo microdosed (microdosing is tirzepatide, not semaglutide) · the needle-free option is one "Oral GLP-1" product covering either molecule, priced from $9 a day on a 3-month prepay |
| Coverage | US only; restrictions by state, confirmed at intake | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.
Telos Rx: The $49 and $99 headlines are FIRST-MONTH rates on prepaid oral plans, not annual-lock rates: Telos itself labels them "first month", renewing at $129 and $139, and bills in 4/12/24/48-week cycles rather than calendar months. Standing injectable rates are $99 semaglutide and $139 tirzepatide; everything outside GLP-1 stays unpriced until intake.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.